Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis Volume 8, 2007 - Issue 6
Journal homepage
171
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects

Srikanth Ranganathan Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, MD, USA
,
Georgina C. B. Nicholl Departments of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
,
Sarah Henry Departments of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
,
Fran Lutka Departments of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
,
Ramasri Sathanoori Lofstrand Labs Limited, Gaithersburg, MD, USA
,
David Lacomis Departments of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
&
Robert Bowser Departments of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USACorrespondence[email protected]
 show all
Pages 373-379 | Received 31 Jan 2007, Accepted 25 Jun 2007, Published online: 10 Jul 2009

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Alexander G Thompson, Patrick Oeckl, Emily Feneberg, Robert Bowser, Markus Otto, Roman Fischer, Benedikt Kessler & Martin R Turner. (2021) Advancing mechanistic understanding and biomarker development in amyotrophic lateral sclerosis. Expert Review of Proteomics 18:11, pages 977-994.
Read now
Peggy Barschke, Patrick Oeckl, Petra Steinacker, Albert Ludolph & Markus Otto. (2017) Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis. Expert Review of Proteomics 14:9, pages 769-777.
Read now

Articles from other publishers (13)

Jared S. Katzeff, Fiona Bright, Katherine Phan, Jillian J. Kril, Lars M. Ittner, Michael Kassiou, John R. Hodges, Olivier Piguet, Matthew C. Kiernan, Glenda M. Halliday & Woojin Scott Kim. (2022) Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis. Brain 145:5, pages 1598-1609.
Crossref
Cory J. Holdom, Frederik J. Steyn, Robert D. Henderson, Pamela A. McCombe, Mary-Louise Rogers & Shyuan T. Ngo. 2022. Neurodegenerative Diseases Biomarkers. Neurodegenerative Diseases Biomarkers 263 306 .
Darija Šoltić, Melissa Bowerman, Joanne Stock, Hannah Shorrock, Thomas Gillingwater & Heidi Fuller. (2018) Multi-Study Proteomic and Bioinformatic Identification of Molecular Overlap between Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA). Brain Sciences 8:12, pages 212.
Crossref
Briony Murphy, Joseph E. Ibrahim, Lyndal Bugeja, Jennifer Pilgrim & Flavia Cicuttini. (2017) The Use of Deceased Controls in Epidemiologic Research: A Systematic Review. American Journal of Epidemiology 186:3, pages 367-384.
Crossref
Annapurna Nayak, Gregory Salt, Sunil K. Verma & Uday Kishore. 2015. Omic Studies of Neurodegenerative Disease: Part A. Omic Studies of Neurodegenerative Disease: Part A 59 86 .
Chi-Shin Hwang, Guan-Ting Liu, Margaret Dah-Tsyr Chang, I-Lin Liao & Hao-Teng Chang. (2013) Elevated serum autoantibody against high mobility group box 1 as a potent surrogate biomarker for amyotrophic lateral sclerosis. Neurobiology of Disease 58, pages 13-18.
Crossref
Pang-ning Teng, Nicholas W. Bateman, Brian L. Hood & Thomas P. Conrads. (2010) Advances in Proximal Fluid Proteomics for Disease Biomarker Discovery. Journal of Proteome Research 9:12, pages 6091-6100.
Crossref
J. Matías-Guiu, L. Galán, R. García-Ramos, J.A. Barcia & A. Guerrero. (2010) La citotoxicidad del líquido cefalorraquídeo en la esclerosis lateral amiotrófica. Neurología 25:6, pages 364-373.
Crossref
J. Matías-Guiu, L. Galán, R. García-Ramos, J.A. Barcia & A. Guerrero. (2010) Cerebrospinal fluid cytotoxicity in lateral amyotrophic sclerosis. Neurología (English Edition) 25:6, pages 364-373.
Crossref
Robert Bowser & David Lacomis. (2009) Applying proteomics to the diagnosis and treatment of ALS and related diseases. Muscle & Nerve 40:5, pages 753-762.
Crossref
Martin R Turner, Matthew C Kiernan, P Nigel Leigh & Kevin Talbot. (2009) Biomarkers in amyotrophic lateral sclerosis. The Lancet Neurology 8:1, pages 94-109.
Crossref
Jeremy M. Shefner. (2008) Designing Clinical Trials in Amyotrophic Lateral Sclerosis. Physical Medicine and Rehabilitation Clinics of North America 19:3, pages 495-508.
Crossref
Michael Swash. (2007) Learning from failed trials in ALS. The Lancet Neurology 6:12, pages 1034-1035.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.